Raltegravir - Revision history

ClaireLewis: /* References */

2019-09-23T22:15:00Z

References

← Revisión anterior		Revisión del 22:15 23 sep 2019
Línea 55:		Línea 55:
	*https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911		*https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Rossdonaldson1: /* Renal Dosing */

2018-03-29T19:52:42Z

Renal Dosing

← Revisión anterior		Revisión del 19:52 29 mar 2018
Línea 19:		Línea 19:

	===Renal Dosing===		===Renal Dosing===
	**Mild to Moderate renal disease: No dosage adjustment necessary		*Mild to Moderate renal disease: No dosage adjustment necessary
	**ESRD on HD: Dose after dialysis on dialysis days		*ESRD on HD: Dose after dialysis on dialysis days

	===Hepatic Dosing===		===Hepatic Dosing===
	No dosage adjustment necessary		No dosage adjustment necessary

Rossdonaldson1 at 19:52, 29 March 2018

2018-03-29T19:52:10Z

← Revisión anterior		Revisión del 19:52 29 mar 2018
Línea 17:		Línea 17:
	*[[Drug pregnancy categories\|Pregnancy Rating]]: C		*[[Drug pregnancy categories\|Pregnancy Rating]]: C
	*Lactation risk: Unknown		*Lactation risk: Unknown

	===Renal Dosing===		===Renal Dosing===
	**Mild to Moderate renal disease: No dosage adjustment necessary		**Mild to Moderate renal disease: No dosage adjustment necessary
Línea 31:		Línea 32:
	*Anaphylaxis		*Anaphylaxis
	*Myopathy/[[Rhabdomyolysis]]		*Myopathy/[[Rhabdomyolysis]]

	===Common===		===Common===
	*Hepatic- increased transaminases		*Hepatic- increased transaminases
Línea 49:		Línea 51:

	==References==		==References==
	~~<ref>https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911</ref>~~
	<references/>		<references/>
			*https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911

	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Jglee3 at 06:59, 19 March 2018

2018-03-19T06:59:34Z

← Revisión anterior		Revisión del 06:59 19 mar 2018
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*Recommended as part of a regimen including Tenofovir plus Emtricitabine or Lamivudine		Recommended as part of a regimen including Tenofovir plus Emtricitabine or Lamivudine
	*Treatment-naive: 400 mg BID or 1200 mg daily		*Treatment-naive: 400 mg BID or 1200 mg daily
	*Treatment-experienced: 400 mg BID		*Treatment-experienced: 400 mg BID

Jglee3 at 06:57, 19 March 2018

2018-03-19T06:57:51Z

← Revisión anterior		Revisión del 06:57 19 mar 2018
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*Recommended as part of a regimen including [[Tenofovir]] plus Emtricitabine or Lamivudine		*Recommended as part of a regimen including Tenofovir plus Emtricitabine or Lamivudine
	*Treatment-naive: 400 mg BID or 1200 mg daily		*Treatment-naive: 400 mg BID or 1200 mg daily
	*Treatment-experienced: 400 mg BID		*Treatment-experienced: 400 mg BID

Jglee3 at 06:57, 19 March 2018

2018-03-19T06:57:14Z

← Revisión anterior		Revisión del 06:57 19 mar 2018
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*Treatment-naive:		*Recommended as part of a regimen including [[Tenofovir]] plus Emtricitabine or Lamivudine
			*Treatment-naive: 400 mg BID or 1200 mg daily
			*Treatment-experienced: 400 mg BID

	==Pediatric Dosing==		==Pediatric Dosing==
			Oral suspension (10 mg/mL): 6 mg/kg/dose BID
			*Maximum dose: 100 mg/dose

	==Special Populations==		==Special Populations==
Línea 19:		Línea 22:
	===Hepatic Dosing===		===Hepatic Dosing===
	No dosage adjustment necessary		No dosage adjustment necessary


	==Contraindications==		==Contraindications==
Línea 33:		Línea 35:

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 9 hours
	*Metabolism:		*Metabolism: Hepatic glucuronidation
	*Excretion:		*Excretion: Renal

	==Mechanism of Action==		==Mechanism of Action==
			*Reverse transcriptase inhibitor

	==Comments==		==Comments==
Línea 47:		Línea 49:

	==References==		==References==
			<ref>https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911</ref>
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Jglee3 at 06:47, 19 March 2018

2018-03-19T06:47:19Z

← Revisión anterior		Revisión del 06:47 19 mar 2018
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type:		*Type: Antiretroviral, Integrase inhibitor
	*Dosage Forms:		*Dosage Forms: 400 mg, 600 mg tablet
	*Routes of Administration:		*Routes of Administration: PO
	*Common Trade Names:		*Common Trade Names: Isentress

	==Adult Dosing==		==Adult Dosing==
			*Treatment-naive:

	==Pediatric Dosing==		==Pediatric Dosing==
Línea 12:		Línea 12:

	==Special Populations==		==Special Populations==
	*[[Drug pregnancy categories\|Pregnancy Rating]]:		*[[Drug pregnancy categories\|Pregnancy Rating]]: C
	*Lactation risk:		*Lactation risk: Unknown
	===Renal Dosing===		===Renal Dosing===
	*~~Adult~~:		**Mild to Moderate renal disease: No dosage adjustment necessary
	*~~Pediatric~~:		**ESRD on HD: Dose after dialysis on dialysis days
	===Hepatic Dosing===		===Hepatic Dosing===
	*Adult:		No dosage adjustment necessary
	*Pediatric:

	==Contraindications==		==Contraindications==
Línea 26:		Línea 26:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
			*[[Stevens-Johnson Syndrome]]
			*Anaphylaxis
			*Myopathy/[[Rhabdomyolysis]]
	===Common===		===Common===
			*Hepatic- increased transaminases

	==Pharmacology==		==Pharmacology==

Rossdonaldson1: Created page with "==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug pregnancy..."

2017-11-19T22:27:15Z

Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug pregnancy..."

Página nueva

==Administration==
*Type:
*Dosage Forms:
*Routes of Administration:
*Common Trade Names:

==Adult Dosing==

==Pediatric Dosing==

==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]:
*Lactation risk:
===Renal Dosing===
*Adult:
*Pediatric:
===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]

Raltegravir - Revision history

ClaireLewis: /* References */

Rossdonaldson1: /* Renal Dosing */

Rossdonaldson1 at 19:52, 29 March 2018

Jglee3 at 06:59, 19 March 2018

Jglee3 at 06:57, 19 March 2018

Jglee3 at 06:57, 19 March 2018

Jglee3 at 06:47, 19 March 2018

Rossdonaldson1: Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug pregnancy..."

Rossdonaldson1: Created page with "==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug pregnancy..."